Weiss Multi-Strategy Advisers’s Novartis NVS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-11,160	Closed	-$850K	–	872
2014 Q1	$850K	Buy	+11,160	New	+$813K	0.02%	530

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVS Position: Q2 2020 in Review

Weiss Multi-Strategy Advisers sold out of Novartis (NVS) in Q2 2020, closing a stake of 24,077 shares — an estimated $1.99M sold.

Weiss Multi-Strategy Advisers first reported a position in NVS in Q4 2013 and held it in 25 quarters. The position peaked at $5.3M in Q4 2013. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Weiss Multi-Strategy Advisers reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 24,077 Novartis shares in Q2 2020, an estimated $1.99M.
Weiss Multi-Strategy Advisers first reported a position in Novartis in Q4 2013 and held it in 25 quarters.
Weiss Multi-Strategy Advisers's Novartis position peaked at $5.3M in Q4 2013.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.